STUART LARSON: Open Payments
NPI 1124178009 · DANVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,757 in 158 payments from 18 companies in 2025. Trend: 2023 $1,578 · 2024 $2,227 · 2025 $2,757
Food & beverage: $2,708Education: $49
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 22 | $354 |
| Otsuka America Pharmaceutical, Inc. | 16 | $309 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $308 |
| ABBVIE INC. | 18 | $265 |
| E.R. Squibb & Sons, L.L.C. | 13 | $265 |
| Janssen Pharmaceuticals, Inc | 10 | $232 |
| Alkermes, Inc. | 11 | $200 |
| Axsome Therapeutics, Inc. | 8 | $170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $140 |
| Corium, LLC | 4 | $92 |
Products named: FANAPT, CAPLYTA, VRAYLAR, COBENFY, REXULTI, INVEGA SUSTENNA, Auvelity, LYBALVI.
Industry payments across KY — which companies pay providers there.
